These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 28922087)

  • 1. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
    Salz T; Zabor EC; de Nully Brown P; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Vickers AJ; Svenssen Munksgaard P; Oeffinger KC; Johansen C
    J Clin Oncol; 2017 Dec; 35(34):3837-3843. PubMed ID: 28922087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Preexisting Heart Failure With Outcomes in Older Patients With Diffuse Large B-Cell Lymphoma.
    Upshaw JN; Nelson J; Rodday AM; Kumar AJ; Klein AK; Konstam MA; Wong JB; Jaffe IZ; Ky B; Friedberg JW; Maurer M; Kent DM; Parsons SK
    JAMA Cardiol; 2023 May; 8(5):453-461. PubMed ID: 36988926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors.
    Salz T; Zabor EC; Brown PN; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Hjalgrim H; Specht L; Vickers AJ; Oeffinger KC; Johansen C
    Acta Oncol; 2022 Sep; 61(9):1064-1068. PubMed ID: 36256902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.
    van Nimwegen FA; Ntentas G; Darby SC; Schaapveld M; Hauptmann M; Lugtenburg PJ; Janus CPM; Daniels L; van Leeuwen FE; Cutter DJ; Aleman BMP
    Blood; 2017 Apr; 129(16):2257-2265. PubMed ID: 28143884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors.
    Ocier K; Abdelaziz S; Kim S; Rowe K; Snyder J; Deshmukh V; Newman M; Fraser A; Smith K; Porucznik CA; Shoaf K; Stanford JB; Lee CJ; Hashibe M
    Cancer Med; 2021 Jun; 10(12):4117-4126. PubMed ID: 33979029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Cardioprotection Reduces Mortality in Lymphoma Patients with Increased Risk of Anthracycline Cardiotoxicity, Treated by R-CHOP Regimen.
    Długosz-Danecka M; Gruszka AM; Szmit S; Olszanecka A; Ogórka T; Sobociński M; Jaroszyński A; Krawczyk K; Skotnicki AB; Jurczak W
    Chemotherapy; 2018; 63(4):238-245. PubMed ID: 30372698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
    Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
    JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in the Development of Anthracycline-Associated Heart Failure.
    Diaz ANR; Hurtado GP; Manzano AAA; Keyes MJ; Turissini C; Choudhary A; Curtin C; Dommaraju S; Warack S; Strom JB; Asnani A
    J Card Fail; 2024 Jul; 30(7):907-914. PubMed ID: 37951494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.
    Vo JB; Ramin C; Veiga LHS; Brandt C; Curtis RE; Bodelon C; Barac A; Roger VL; Feigelson HS; Buist DSM; Bowles EJA; Gierach GL; Berrington de González A
    J Natl Cancer Inst; 2024 Aug; 116(8):1384-1394. PubMed ID: 38718210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort.
    Leo QJ; Ollberding NJ; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L; Maskarinec G
    Eur J Clin Nutr; 2016 Jan; 70(1):41-6. PubMed ID: 26330148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Risk of Heart Failure and Other Cardiovascular Hospitalizations After Early Stage Breast Cancer: A Matched Cohort Study.
    Abdel-Qadir H; Thavendiranathan P; Austin PC; Lee DS; Amir E; Tu JV; Fung K; Anderson GM
    J Natl Cancer Inst; 2019 Aug; 111(8):854-862. PubMed ID: 30715404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congestive heart failure in older adults diagnosed with follicular lymphoma: A population-based study.
    Kenzik KM; Mehta A; Richman JS; Kilgore M; Bhatia S
    Cancer; 2018 Nov; 124(21):4221-4230. PubMed ID: 30303522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H; Kadri AN; Hernandez AV
    Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study.
    Ehrhardt MJ; Chen Y; Sandlund JT; Bluhm EC; Hayashi RJ; Becktell K; Leisenring WM; Metzger ML; Ness KK; Krull KR; Oeffinger KC; Gibson TM; Cairo MS; Gross TG; Robison LL; Armstrong GT; Yasui Y; Hudson MM; Mulrooney DA
    J Clin Oncol; 2019 Oct; 37(28):2556-2570. PubMed ID: 31283408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
    Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
    Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of heart failure after systemic treatment for early breast cancer: results of a cohort study.
    Jacobse JN; Schaapveld M; Boekel NB; Hooning MJ; Jager A; Baaijens MHA; Hauptmann M; Russell NS; Rutgers EJT; Aleman BMP; Sonke GS; van Leeuwen FE
    Breast Cancer Res Treat; 2021 Jan; 185(1):205-214. PubMed ID: 32964358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
    Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
    Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
    Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
    JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.